Stay updated on DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial

Sign up to get notified when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error page instead of the study details, indicating access to the record is blocked.
    Difference
    16%
    Check dated 2026-09-19T20:54:30.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page no longer displays the primary condition 'Type 2 diabetes' and the 'related topics' section including 'MedlinePlus Genetics', reducing explicit disease context and linked resources for the study.
    Difference
    0.1%
    Check dated 2026-09-12T18:39:01.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added 'Type 2 diabetes' as a topic tag. Introduced a related topics entry featuring MedlinePlus Genetics to connect the study to genetics resources.
    Difference
    0.1%
    Check dated 2026-09-05T20:45:05.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    New page revision tag added: Revision: v3.6.6. The 'Type 2 diabetes' descriptor and the related topic 'MedlinePlus Genetics' are removed from the page, changing how the study's condition and topics are presented.
    Difference
    0.1%
    Check dated 2026-08-29T20:18:10.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Added the Type 2 diabetes topic and a related topics entry linking to MedlinePlus Genetics. Updated the revision tag from v3.6.4 to v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-08T23:00:48.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The MedlinePlus related topics section no longer lists 'Diabetes Type 2' and 'MedlinePlus Genetics', removing these consumer health resource links from the page.
    Difference
    0.1%
    Check dated 2026-08-01T18:03:34.000Z thumbnail image

Stay in the know with updates to DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.